Speaker illustration

Ms Mahshid Eslami

Vienna (Austria)

Member of:

European Society of Cardiology

Biomarker-based clinical evaluation in ATTR-CM: plasma fibroblast-growth-factor-23 assessment

Event: ESC Congress 2025

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Molecular mechanisms in heart failure

Thumbnail